226 related articles for article (PubMed ID: 15627307)
1. Modified release tacrolimus.
First MR; Fitzsimmons WE
Yonsei Med J; 2004 Dec; 45(6):1127-31. PubMed ID: 15627307
[TBL] [Abstract][Full Text] [Related]
2. Conversion of stable kidney transplant recipients from a twice daily Prograf-based regimen to a once daily modified release tacrolimus-based regimen.
Alloway R; Steinberg S; Khalil K; Gourishankar S; Miller J; Norman D; Hariharan S; Pirsch J; Matas A; Zaltzman J; Wisemandle K; Fitzsimmons W; First MR
Transplant Proc; 2005 Mar; 37(2):867-70. PubMed ID: 15848559
[TBL] [Abstract][Full Text] [Related]
3. Conversion of stable liver transplant recipients from a twice-daily Prograf-based regimen to a once-daily modified release tacrolimus-based regimen.
Florman S; Alloway R; Kalayoglu M; Lake K; Bak T; Klein A; Klintmalm G; Busque S; Brandenhagen D; Lake J; Wisemandle K; Fitzsimmons W; First MR
Transplant Proc; 2005 Mar; 37(2):1211-3. PubMed ID: 15848672
[TBL] [Abstract][Full Text] [Related]
4. Conversion from twice daily tacrolimus capsules to once daily extended-release tacrolimus (LCP-Tacro): phase 2 trial of stable liver transplant recipients.
Alloway RR; Eckhoff DE; Washburn WK; Teperman LW
Liver Transpl; 2014 May; 20(5):564-75. PubMed ID: 24493215
[TBL] [Abstract][Full Text] [Related]
5. Clinical Pharmacokinetics of Once-Daily Tacrolimus in Solid-Organ Transplant Patients.
Staatz CE; Tett SE
Clin Pharmacokinet; 2015 Oct; 54(10):993-1025. PubMed ID: 26038096
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of conversion from twice-daily tacrolimus (prograf) to once-daily prolonged-release tacrolimus (graceptor) in stable kidney transplant recipients.
Nakamura Y; Hama K; Katayama H; Soga A; Toraishi T; Yokoyama T; Kihara Y; Jojima Y; Konno O; Iwamoto H; Takeuchi H; Hirano T; Shimazu M
Transplant Proc; 2012 Jan; 44(1):124-7. PubMed ID: 22310595
[TBL] [Abstract][Full Text] [Related]
7. Safety of conversion from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in stable liver transplant recipients.
Comuzzi C; Lorenzin D; Rossetto A; Faraci MG; Nicolini D; Garelli P; Bresadola V; Toniutto P; Soardo G; Baroni GS; Adani GL; Risaliti A; Baccarani U
Transplant Proc; 2010 May; 42(4):1320-1. PubMed ID: 20534291
[TBL] [Abstract][Full Text] [Related]
8. Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients.
Alloway R; Steinberg S; Khalil K; Gourishankar S; Miller J; Norman D; Hariharan S; Pirsch J; Matas A; Zaltzman J; Wisemandle K; Fitzsimmons W; First MR
Transplantation; 2007 Jun; 83(12):1648-51. PubMed ID: 17589351
[TBL] [Abstract][Full Text] [Related]
9. First clinical experience with the new once-daily formulation of tacrolimus.
First MR
Ther Drug Monit; 2008 Apr; 30(2):159-66. PubMed ID: 18367975
[TBL] [Abstract][Full Text] [Related]
10. Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients.
Florman S; Alloway R; Kalayoglu M; Punch J; Bak T; Melancon J; Klintmalm G; Busque S; Charlton M; Lake J; Dhadda S; Wisemandle K; Wirth M; Fitzsimmons W; Holman J; First MR
Transplantation; 2007 Jun; 83(12):1639-42. PubMed ID: 17589349
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics in stable kidney transplant recipients after conversion from twice-daily to once-daily tacrolimus formulations.
van Hooff J; Van der Walt I; Kallmeyer J; Miller D; Dawood S; Moosa MR; Christiaans M; Karpf C; Undre N
Ther Drug Monit; 2012 Feb; 34(1):46-52. PubMed ID: 22249344
[TBL] [Abstract][Full Text] [Related]
12. Significant reduction of Tacrolimus trough level after conversion from twice daily Prograf to once daily Advagraf in Chinese renal transplant recipients with or without concomitant diltiazem treatment.
Ma MK; Kwan LP; Mok MM; Yap DY; Tang CS; Chan TM
Ren Fail; 2013 Aug; 35(7):942-5. PubMed ID: 23815459
[TBL] [Abstract][Full Text] [Related]
13. Conversion from twice-daily tacrolimus capsules to once-daily extended-release tacrolimus (LCPT): a phase 2 trial of stable renal transplant recipients.
Gaber AO; Alloway RR; Bodziak K; Kaplan B; Bunnapradist S
Transplantation; 2013 Jul; 96(2):191-7. PubMed ID: 23715050
[TBL] [Abstract][Full Text] [Related]
14. Reduced variability of tacrolimus trough level in once-daily tacrolimus-based Taiwanese kidney transplant recipients with high-expressive genotype of cytochrome P450 3A5.
Wu MJ; Chang CH; Cheng CY; Shu KH; Chen CH; Cheng CH; Yu TM; Chuang YW; Huang ST; Tsai SF; Ho HC; Li JR; Shiu YN; Fu YC
Transplant Proc; 2014; 46(2):403-5. PubMed ID: 24655974
[TBL] [Abstract][Full Text] [Related]
15. Renal function and safety in stable kidney transplant recipients converted from immediate-release to prolonged-release tacrolimus.
Lauzurica R; Morales JM; van Hooff J;
Transpl Int; 2012 Jan; 25(1):48-55. PubMed ID: 21992068
[TBL] [Abstract][Full Text] [Related]
16. Once daily tacrolimus formulation: monitoring of plasma levels, graft function, and cardiovascular risk factors.
Meçule A; Poli L; Nofroni I; Bachetoni A; Tinti F; Umbro I; Barile M; Berloco PB; Mitterhofer AP
Transplant Proc; 2010 May; 42(4):1317-9. PubMed ID: 20534290
[TBL] [Abstract][Full Text] [Related]
17. Modified-release tacrolimus.
Chisholm MA; Middleton MD
Ann Pharmacother; 2006 Feb; 40(2):270-5. PubMed ID: 16449540
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of tacrolimus converted from twice-daily formulation to once-daily formulation in Chinese stable liver transplant recipients.
Zhang YF; Chen XY; Dai XJ; Leng XS; Zhong DF
Acta Pharmacol Sin; 2011 Nov; 32(11):1419-23. PubMed ID: 21963896
[TBL] [Abstract][Full Text] [Related]
19. Early conversion from twice-daily tacrolimus to once-daily extended formulation in renal transplant patients before hospital discharge.
Jannot M; Masson I; Alamartine E; Mariat C
Ann Transplant; 2014 Jul; 19():320-4. PubMed ID: 24999809
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of stable kidney transplant recipients after conversion from tacrolimus twice daily immediate release to tacrolimus once-daily prolonged release: a large single-center experience.
Slatinska J; Rohal T; Wohlfahrtova M; Viklicky O
Transplant Proc; 2013 May; 45(4):1491-6. PubMed ID: 23726604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
